 | • レポートコード：GIR-107A14058 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、マルチプレックスバイオマーカーイメージングのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。マルチプレックスバイオマーカーイメージングの種類別市場規模（免疫組織化学（IHC）アッセイ、蛍光in Situ、ハイブリダイゼーション（FISH）アッセイ、組織マイクロアレイ（TMA）アッセイ）、用途別市場規模（転移術研究所、バイオ製薬会社、学術機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・マルチプレックスバイオマーカーイメージングの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：PerkinElmer、Bio-Rad Laboratories、Thermo Fisher、US Biomax、Abcam ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：免疫組織化学（IHC）アッセイ、蛍光in Situ、ハイブリダイゼーション（FISH）アッセイ、組織マイクロアレイ（TMA）アッセイ ・用途別分析2016年-2026年：転移術研究所、バイオ製薬会社、学術機関 ・マルチプレックスバイオマーカーイメージングの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・マルチプレックスバイオマーカーイメージングのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・マルチプレックスバイオマーカーイメージングのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・マルチプレックスバイオマーカーイメージングの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・マルチプレックスバイオマーカーイメージングの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Multiplex Biomarker Imaging market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Multiplex Biomarker Imaging size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Multiplex Biomarker Imaging market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Multiplex Biomarker Imaging market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunohistochemistry (IHC) Assay
Fluorescent In Situ
Hybridization (FISH) Assay
Tissue Microarray (TMA) Assay
Market segment by Application, can be divided into
Translation Laboratories
Biopharmaceutical Companies
Academic Institutes
Market segment by players, this report covers
PerkinElmer
Bio-Rad Laboratories
Thermo Fisher
US Biomax
Abcam
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Multiplex Biomarker Imaging product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Multiplex Biomarker Imaging, with revenue, gross margin and global market share of Multiplex Biomarker Imaging from 2019 to 2021.
Chapter 3, the Multiplex Biomarker Imaging competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Multiplex Biomarker Imaging market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Multiplex Biomarker Imaging research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Multiplex Biomarker Imaging
1.2 Classification of Multiplex Biomarker Imaging by Type
1.2.1 Overview: Global Multiplex Biomarker Imaging Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Multiplex Biomarker Imaging Revenue Market Share by Type in 2020
1.2.3 Immunohistochemistry (IHC) Assay
1.2.4 Fluorescent In Situ
1.2.5 Hybridization (FISH) Assay
1.2.6 Tissue Microarray (TMA) Assay
1.3 Global Multiplex Biomarker Imaging Market by Application
1.3.1 Overview: Global Multiplex Biomarker Imaging Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Translation Laboratories
1.3.3 Biopharmaceutical Companies
1.3.4 Academic Institutes
1.4 Global Multiplex Biomarker Imaging Market Size & Forecast
1.5 Global Multiplex Biomarker Imaging Market Size and Forecast by Region
1.5.1 Global Multiplex Biomarker Imaging Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Multiplex Biomarker Imaging Market Size by Region, (2016-2021)
1.5.3 North America Multiplex Biomarker Imaging Market Size and Prospect (2016-2026)
1.5.4 Europe Multiplex Biomarker Imaging Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Multiplex Biomarker Imaging Market Size and Prospect (2016-2026)
1.5.6 South America Multiplex Biomarker Imaging Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Multiplex Biomarker Imaging Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Multiplex Biomarker Imaging Market Drivers
1.6.2 Multiplex Biomarker Imaging Market Restraints
1.6.3 Multiplex Biomarker Imaging Trends Analysis
2 Company Profiles
2.1 PerkinElmer
2.1.1 PerkinElmer Details
2.1.2 PerkinElmer Major Business
2.1.3 PerkinElmer Multiplex Biomarker Imaging Product and Solutions
2.1.4 PerkinElmer Multiplex Biomarker Imaging Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 PerkinElmer Recent Developments and Future Plans
2.2 Bio-Rad Laboratories
2.2.1 Bio-Rad Laboratories Details
2.2.2 Bio-Rad Laboratories Major Business
2.2.3 Bio-Rad Laboratories Multiplex Biomarker Imaging Product and Solutions
2.2.4 Bio-Rad Laboratories Multiplex Biomarker Imaging Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.3 Thermo Fisher
2.3.1 Thermo Fisher Details
2.3.2 Thermo Fisher Major Business
2.3.3 Thermo Fisher Multiplex Biomarker Imaging Product and Solutions
2.3.4 Thermo Fisher Multiplex Biomarker Imaging Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Thermo Fisher Recent Developments and Future Plans
2.4 US Biomax
2.4.1 US Biomax Details
2.4.2 US Biomax Major Business
2.4.3 US Biomax Multiplex Biomarker Imaging Product and Solutions
2.4.4 US Biomax Multiplex Biomarker Imaging Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 US Biomax Recent Developments and Future Plans
2.5 Abcam
2.5.1 Abcam Details
2.5.2 Abcam Major Business
2.5.3 Abcam Multiplex Biomarker Imaging Product and Solutions
2.5.4 Abcam Multiplex Biomarker Imaging Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Abcam Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Multiplex Biomarker Imaging Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Multiplex Biomarker Imaging Players Market Share
3.2.2 Top 10 Multiplex Biomarker Imaging Players Market Share
3.2.3 Market Competition Trend
3.3 Multiplex Biomarker Imaging Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Multiplex Biomarker Imaging Revenue and Market Share by Type (2016-2021)
4.2 Global Multiplex Biomarker Imaging Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Multiplex Biomarker Imaging Revenue Market Share by Application (2016-2021)
5.2 Multiplex Biomarker Imaging Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Multiplex Biomarker Imaging Revenue by Type (2016-2026)
6.2 North America Multiplex Biomarker Imaging Revenue by Application (2016-2026)
6.3 North America Multiplex Biomarker Imaging Market Size by Country
6.3.1 North America Multiplex Biomarker Imaging Revenue by Country (2016-2026)
6.3.2 United States Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
6.3.3 Canada Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
6.3.4 Mexico Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Multiplex Biomarker Imaging Revenue by Type (2016-2026)
7.2 Europe Multiplex Biomarker Imaging Revenue by Application (2016-2026)
7.3 Europe Multiplex Biomarker Imaging Market Size by Country
7.3.1 Europe Multiplex Biomarker Imaging Revenue by Country (2016-2026)
7.3.2 Germany Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
7.3.3 France Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
7.3.5 Russia Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
7.3.6 Italy Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Multiplex Biomarker Imaging Revenue by Type (2016-2026)
8.2 Asia-Pacific Multiplex Biomarker Imaging Revenue by Application (2016-2026)
8.3 Asia-Pacific Multiplex Biomarker Imaging Market Size by Region
8.3.1 Asia-Pacific Multiplex Biomarker Imaging Revenue by Region (2016-2026)
8.3.2 China Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
8.3.3 Japan Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
8.3.4 South Korea Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
8.3.5 India Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
8.3.7 Australia Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Multiplex Biomarker Imaging Revenue by Type (2016-2026)
9.2 South America Multiplex Biomarker Imaging Revenue by Application (2016-2026)
9.3 South America Multiplex Biomarker Imaging Market Size by Country
9.3.1 South America Multiplex Biomarker Imaging Revenue by Country (2016-2026)
9.3.2 Brazil Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
9.3.3 Argentina Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Multiplex Biomarker Imaging Revenue by Type (2016-2026)
10.2 Middle East & Africa Multiplex Biomarker Imaging Revenue by Application (2016-2026)
10.3 Middle East & Africa Multiplex Biomarker Imaging Market Size by Country
10.3.1 Middle East & Africa Multiplex Biomarker Imaging Revenue by Country (2016-2026)
10.3.2 Turkey Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
10.3.4 UAE Multiplex Biomarker Imaging Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Multiplex Biomarker Imaging Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Multiplex Biomarker Imaging Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Multiplex Biomarker Imaging Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Multiplex Biomarker Imaging Revenue (USD Million) by Region (2016-2021)
Table 5. Global Multiplex Biomarker Imaging Revenue Market Share by Region (2021-2026)
Table 6. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 7. PerkinElmer Major Business
Table 8. PerkinElmer Multiplex Biomarker Imaging Product and Solutions
Table 9. PerkinElmer Multiplex Biomarker Imaging Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Bio-Rad Laboratories Major Business
Table 12. Bio-Rad Laboratories Multiplex Biomarker Imaging Product and Solutions
Table 13. Bio-Rad Laboratories Multiplex Biomarker Imaging Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Thermo Fisher Corporate Information, Head Office, and Major Competitors
Table 15. Thermo Fisher Major Business
Table 16. Thermo Fisher Multiplex Biomarker Imaging Product and Solutions
Table 17. Thermo Fisher Multiplex Biomarker Imaging Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. US Biomax Corporate Information, Head Office, and Major Competitors
Table 19. US Biomax Major Business
Table 20. US Biomax Multiplex Biomarker Imaging Product and Solutions
Table 21. US Biomax Multiplex Biomarker Imaging Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Abcam Corporate Information, Head Office, and Major Competitors
Table 23. Abcam Major Business
Table 24. Abcam Multiplex Biomarker Imaging Product and Solutions
Table 25. Abcam Multiplex Biomarker Imaging Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Multiplex Biomarker Imaging Revenue (USD Million) by Players (2019-2021)
Table 27. Global Multiplex Biomarker Imaging Revenue Share by Players (2019-2021)
Table 28. Breakdown of Multiplex Biomarker Imaging by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Multiplex Biomarker Imaging Players Head Office, Products and Services Provided
Table 30. Multiplex Biomarker Imaging Mergers & Acquisitions in the Past Five Years
Table 31. Multiplex Biomarker Imaging New Entrants and Expansion Plans
Table 32. Global Multiplex Biomarker Imaging Revenue (USD Million) by Type (2016-2021)
Table 33. Global Multiplex Biomarker Imaging Revenue Share by Type (2016-2021)
Table 34. Global Multiplex Biomarker Imaging Revenue Forecast by Type (2021-2026)
Table 35. Global Multiplex Biomarker Imaging Revenue by Application (2016-2021)
Table 36. Global Multiplex Biomarker Imaging Revenue Forecast by Application (2021-2026)
Table 37. North America Multiplex Biomarker Imaging Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Multiplex Biomarker Imaging Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Multiplex Biomarker Imaging Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Multiplex Biomarker Imaging Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Multiplex Biomarker Imaging Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Multiplex Biomarker Imaging Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Multiplex Biomarker Imaging Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Multiplex Biomarker Imaging Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Multiplex Biomarker Imaging Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Multiplex Biomarker Imaging Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Multiplex Biomarker Imaging Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Multiplex Biomarker Imaging Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Multiplex Biomarker Imaging Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Multiplex Biomarker Imaging Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Multiplex Biomarker Imaging Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Multiplex Biomarker Imaging Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Multiplex Biomarker Imaging Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Multiplex Biomarker Imaging Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Multiplex Biomarker Imaging Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Multiplex Biomarker Imaging Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Multiplex Biomarker Imaging Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Multiplex Biomarker Imaging Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Multiplex Biomarker Imaging Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Multiplex Biomarker Imaging Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Multiplex Biomarker Imaging Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Multiplex Biomarker Imaging Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Multiplex Biomarker Imaging Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Multiplex Biomarker Imaging Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Multiplex Biomarker Imaging Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Multiplex Biomarker Imaging Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Multiplex Biomarker Imaging Picture
Figure 2. Global Multiplex Biomarker Imaging Revenue Market Share by Type in 2020
Figure 3. Immunohistochemistry (IHC) Assay
Figure 4. Fluorescent In Situ
Figure 5. Hybridization (FISH) Assay
Figure 6. Tissue Microarray (TMA) Assay
Figure 7. Multiplex Biomarker Imaging Revenue Market Share by Application in 2020
Figure 8. Translation Laboratories Picture
Figure 9. Biopharmaceutical Companies Picture
Figure 10. Academic Institutes Picture
Figure 11. Global Multiplex Biomarker Imaging Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Multiplex Biomarker Imaging Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Multiplex Biomarker Imaging Revenue Market Share by Region (2016-2026)
Figure 14. Global Multiplex Biomarker Imaging Revenue Market Share by Region in 2020
Figure 15. North America Multiplex Biomarker Imaging Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Multiplex Biomarker Imaging Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Multiplex Biomarker Imaging Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Multiplex Biomarker Imaging Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Multiplex Biomarker Imaging Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Multiplex Biomarker Imaging Market Drivers
Figure 21. Multiplex Biomarker Imaging Market Restraints
Figure 22. Multiplex Biomarker Imaging Market Trends
Figure 23. PerkinElmer Recent Developments and Future Plans
Figure 24. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 25. Thermo Fisher Recent Developments and Future Plans
Figure 26. US Biomax Recent Developments and Future Plans
Figure 27. Abcam Recent Developments and Future Plans
Figure 28. Global Multiplex Biomarker Imaging Revenue Share by Players in 2020
Figure 29. Multiplex Biomarker Imaging Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Multiplex Biomarker Imaging Revenue Market Share in 2020
Figure 31. Global Top 10 Players Multiplex Biomarker Imaging Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Multiplex Biomarker Imaging Revenue Share by Type in 2020
Figure 34. Global Multiplex Biomarker Imaging Market Share Forecast by Type (2021-2026)
Figure 35. Global Multiplex Biomarker Imaging Revenue Share by Application in 2020
Figure 36. Global Multiplex Biomarker Imaging Market Share Forecast by Application (2021-2026)
Figure 37. North America Multiplex Biomarker Imaging Sales Market Share by Type (2016-2026)
Figure 38. North America Multiplex Biomarker Imaging Sales Market Share by Application (2016-2026)
Figure 39. North America Multiplex Biomarker Imaging Revenue Market Share by Country (2016-2026)
Figure 40. United States Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Multiplex Biomarker Imaging Sales Market Share by Type (2016-2026)
Figure 44. Europe Multiplex Biomarker Imaging Sales Market Share by Application (2016-2026)
Figure 45. Europe Multiplex Biomarker Imaging Revenue Market Share by Country (2016-2026)
Figure 46. Germany Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Multiplex Biomarker Imaging Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Multiplex Biomarker Imaging Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Multiplex Biomarker Imaging Revenue Market Share by Region (2016-2026)
Figure 54. China Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Multiplex Biomarker Imaging Sales Market Share by Type (2016-2026)
Figure 61. South America Multiplex Biomarker Imaging Sales Market Share by Application (2016-2026)
Figure 62. South America Multiplex Biomarker Imaging Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Multiplex Biomarker Imaging Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Multiplex Biomarker Imaging Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Multiplex Biomarker Imaging Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Multiplex Biomarker Imaging Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source
世界の症候群マルチプレックス診断市場 2021：企業別、地域別、種類・用途別 The Syndromic Multiplex Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- タンパク質ベースマルチプレックスアッセイの世界市場 2019年版：種類別（試薬＆消耗品、機器＆アクセサリー、ソフトウェア＆サービス）、用途別（コンパニオン診断、研究開発、臨床診断） Scope of the Report: The global Protein-based Multiplex Assays market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in C…
- 腫瘍学バイオマーカーの世界市場 2019年版：種類別（肺がん、乳がん、大腸がん、前立腺がん、胃がん、その他）、用途別（診断、創薬＆開発、予後、リスクアセスメント、その他） Scope of the Report: The global Oncology Biomarker market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also f…
- 腫瘍バイオマーカー試験市場：世界及び中国市場分析・予測（～2024年） Tumor Biomarker Test Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Tumor Biomarker Test industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tumor Biomarker Test manufac…
- 核酸ベースマルチプレックスアッセイの世界市場 2019年版：種類別（試薬＆消耗品、機器＆アクセサリー、ソフトウェア＆サービス）、用途別（コンパニオン診断、研究開発、臨床診断） Scope of the Report: The global Nucleic Acid-Based Multiplex Assays market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…